23andMe Reports Third Quarter Fiscal 2024 Financial
Announced new non-exclusive data license with GSK, introduced 23andMe Total Health™, and received FDA clearance for IND on novel, dual-mechanism...
Source: globenewswire.com
Selected Variants News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Selected Variants. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Selected Variants Today - Breaking & Trending Today
Are you at risk? New genetic report sheds light on breast cancer risk genes
(BPT) - You don’t always know what’s in your gene pool. Even with a detailed family health history, you may not have a complete picture for what you’re at risk
Source: yesweekly.com
Breast cancer: FDA okays direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
The U.S. Food and Drug Administration this week authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected
Source: theglobaldispatch.com
23Andme Holding Co. Grants New FDA Clearance to Report Additional BRCA Variants
23andMe Holding Co. announced the Company has received a U.S. Food and Drug Administration 510 clearance to expand its existing BRCA1/BRCA2 Genetic Health Risk Report. The clearance allows 23andMe...
Source: marketscreener.com
23andMe Gets FDA Clearance To Report Additional BRCA Variants, Stock Jumps
Shares of 23andMe Holding Co. (ME) are up over 20% at $1.33 in premarket trading Friday, following FDA clearance to expand its existing BRCA1/BRCA2 Genetic Health Risk Report.
Source: rttnews.com